NCIC Clinical Trials Group

Brain Gastro-Intestinal Gynecologic Hematologic Lung Sarcoma
Breast Genito-Urinary Head & Neck IND Melanoma Symptom Control

Spring Meeting Trial Reports: 2011 / 2010 / 2009
ID Study Title Status
SC.18
NCCTG 989255
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Megestrol Acetate (Megace) versus an N-3 Fatty Acid (EPA) Enriched Nutritional Supplement versus Both for the Treatment of Cancer Cachexia and Anorexia (NCCTG: 98-92-55)    MORE... Permanently Closed
SC.19 A Phase III Study of Ondansetron and Dexamethasone versus Ondansetron and Placebo in the Prophylaxis against Radiation-Induced Emesis    MORE... Permanently Closed
SC.20 A Phase III International Randomized Trial of Single versus Multiple Fractions for Re-Irradiation of Painful Bone Metastases    MORE... Open
SC.20U A Phase III Study of the Effect of Re-Irradiation for Bone Pain on Urinary Markers of Osteoclast Activity    MORE... Open
SC.22 A Phase I Study to Determine the Dose of Methadone as a First Line Agent in the Treatment of Chronic Neuropathic Cancer Pain    MORE... Permanently Closed
SC.23 A Randomized Phase III Double Blind Study of Dexamethasone Versus Placebo in the Prophylaxis of Radiation-Induced Pain Flare Following Palliative Radiotherapy for Bone Metastases    MORE... Open

Use this to link back to CTG home only

If you have any questions, comments or suggestions, please contact our